Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...
A technician at Microtest performs bioburden testing using the aseptic technique. There are no commonly accepted levels of environmental bioburden. Industrial sterilization and contamination control ...
(MENAFN- GlobeNewsWire - Nasdaq) The bioburden testing market is set to grow significantly due to increased demand in pharmaceuticals and medical devices and strict regulatory standards. Key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results